BioPharm International® sat down with Noah Kopcho, field application scientist at Gyros Protein Technologies, to talk about ...

As therapeutic modalities evolve, so do the challenges and methodologies associated with maintaining and verifying cleanroom ...

The pandemic made it daunting for companies to retain talent and then find it anew, but just as that cloud is lifting and ...

The pharma industry is focused on strengthening its foundation, embracing innovation, and future-proofing its path forward.

While global harmonization exists, there are still differences between the US and European GMP requirements that ...

Donald Ingber, MD, PhD; Miguel Forte, MD, PhD; Ali Pashazadeh, MRCS, MBA; and Adam Inche, PhD, MBA go behind the headlines to ...

In this episode of the Ask the Expert video series, Susan J. Schniepp, distinguished fellow at Regulatory Compliance ...

How BioDuro is expanding its global CRDMO footprint by improving integrated capabilities and delivering high-quality, ...

Pharmaceutical Technology® spoke with Alexander Seyf, CEO and co-founder of Autolomous, about the impact geopolitical changes in Europe might have on the bio/pharmaceutical industry. Political shifts ...

Aviva Capital Partners and developer Socius are investing £1 billion to develop a cancer research and treatment center in Sutton, London.